Orphan Medical licensed the European sales and marketing rights for its central nervous system depressant, Xyrem® (sodium oxybate) for treating cataplexy to Celltech Pharmaceuticals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: PharmaDeals Ltd